MDI component manufacturer Presspart has announced that it is now known as H&T Presspart to emphasize its status as a subsidiary of the Heitkamp & Thumann Group. The company said that it also plans to add manufacturing sites in Asia and the Americas in order to meet demand for MDI parts in those regions. Presspart already manufactures canisters and actuators in … [Read more...] about MDI component manufacturer Presspart becomes H&T Presspart, plans to add new manufacturing sites
News
MannKind announces 4th quarter results, management changes
According to MannKind Corporation, the company's net loss for 2015 was $368.4 million, and its cash and cash equivalents as of the end of 2015 totaled $59.1 million. The company also said that it has hired former Amgen VP, Global Commercial Lead Michael E. Castagna as its Chief Commercial Officer, effective immediately, and announced the resignation of Chief Operating … [Read more...] about MannKind announces 4th quarter results, management changes
Children’s Flonase now available OTC in the United States
GSK Consumer Healthcare has announced that Children's Flonase fluticasone propionate nasal spray is now available over the counter in the US. The FDA approved OTC sales of Flonase in July 2014, and the product has been available over the counter in the US since February 2015. Children's Flonase appears to be effectively identical to regular Flonase, with 50 mcg of … [Read more...] about Children’s Flonase now available OTC in the United States
Sunovion study shows that COPD patients receive DPIs despite insufficient inspiratory flow rate
Sunovion is presenting observational study data at the Hospital Medicine 2016 conference showing that a substantial number of COPD patients are discharged from hospitals with a prescription for a dry powder inhaler despite their inability to generate sufficient peak inspiratory flow for optimal use of the device. Data from a second study show worse COPD-related … [Read more...] about Sunovion study shows that COPD patients receive DPIs despite insufficient inspiratory flow rate
BI presents data showing Spiriva Respimat effective when added to other asthma therapies
Boehringer Ingelheim has presented data at the 2016 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting showing that the Spiriva Respimat tiotropium bromide soft mist inhaler improves lung function and reduces exacerbations when added to other treatments for all allergic asthma subtypes. The addition of Spiriva Respimat also improved asthma … [Read more...] about BI presents data showing Spiriva Respimat effective when added to other asthma therapies
Tim Freeman receives Richard S. Ladd Standards Development Award from ASTM
Powder testing specialist Freeman Technology has announced that Managing Director Tim Freeman has received the Richard S. Ladd Standards Development Award from the ASTM for development of ASTM Standard Designation D7891 “Standard Test Method for Shear Testing of Powders using the Freeman Technology FT4 Powder Rheometer Shear Cell.” Freeman's FT4 powder rheometer is … [Read more...] about Tim Freeman receives Richard S. Ladd Standards Development Award from ASTM
Cannabinoid developer to collaborate with intranasal delivery company on epilepsy therapy
Australian medical cannabis company MGC Pharmaceuticals has signed a collaboration agreement with Israeli device developer SipNose for development of a cannabinoid therapy for the treatment of epilepsy, the company said. The agreement includes an option for a global license for use of the SipNose device to deliver cannabinoids for epilepsy. According to MGC, the … [Read more...] about Cannabinoid developer to collaborate with intranasal delivery company on epilepsy therapy
Study shows significant overdiagnosis of asthma in children
A study published in the British Journal of General Practice titled "Overdiagnosis of asthma in children in primary care: a retrospective analysis" found that over half of children diagnosed with asthma at several major healthcare centers in the Netherlands probably do not have the disease. Researchers from Julius Health Care Center and University Medical Center … [Read more...] about Study shows significant overdiagnosis of asthma in children
Savara Pharmaceuticals raises $20 million for AeroVanc development
Savara Pharmaceuticals has announced the completion of a $20 million financing round to fund a pivotal Phase 3 clinical trial of its AeroVanc vancomycin DPI for the treatment of MRSA lung infections in cystic fibrosis patients. The company says that it expects enrollment for the study to begin by the end of the year. In February 2015, Savara announced positive … [Read more...] about Savara Pharmaceuticals raises $20 million for AeroVanc development
Impel NeuroPharma licenses intranasal therapy for depression
Intranasal delivery specialist Impel NeuroPharma and the Toronto-based Centre for Addiction and Mental Health (CAMH) have signed a licensing agreement for an intranasal neuropeptide-based therapy for the treatment of depression. The peptide, which was discovered at CAMH, will be delivered using Impel's Precision Olfactory Delivery (POD) device. According to CAMH, … [Read more...] about Impel NeuroPharma licenses intranasal therapy for depression